Phase II study of pomegranate juice for men with rising PSA following surgery or radiation for prostate cancer

被引：5
|
作者：
Pantuck, AJ
Leppert, JT
Zomorodian, N
Seeram, N
Seiler, D
Liker, H
Wang, HJ
Elashoff, R
Heber, D
Belldegrun, AS
机构：
来源：
JOURNAL OF UROLOGY | 2005年 / 173卷 / 04期
关键词：
D O I：
10.1016/S0022-5347(18)35000-6
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
831
引用
收藏
页码：225 / 226
页数：2
相关论文
共 50 条
  • [41] EARLY ONCOLOGIC OUTCOME AND PSA KINETICS FOLLOWING IRREVERSIBLE ELECTROPORATION IN MEN WITH PROSTATE CANCER
    Behzad, Jazayeri Seyed
    Mustafa, Dinckal
    Kenneth, Gage
    Michael, Poch
    Brandon, Manley
    Roger, Li
    Pow-Sang, Julio
    Alice, Yu
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2025, 43 (03) : 77 - 78
  • [42] Predictors of outcome for radiation therapy in prostate cancer patients with rising PSA levels after radical prostatectomy
    Sedlmayer, F
    STRAHLENTHERAPIE UND ONKOLOGIE, 2004, 180 (03) : 182 - 183
  • [43] Phase II Study of Nitric Oxide Donor for Men With Increasing Prostate-specific Antigen Level After Surgery or Radiotherapy for Prostate Cancer
    Siemens, D. Robert
    Heaton, Jeremy P. W.
    Adams, Michael A.
    Kawakami, Jun
    Graham, Charles H.
    UROLOGY, 2009, 74 (04) : 878 - 883
  • [44] Randomized double-blind, placebo-controlled, crossover study of men with prostate cancer and rising PSA:: Effectiveness of a dietary supplement
    Schröder, FH
    Roobol, MJ
    Boevé, ER
    De Mutsert, R
    Verwillegen, W
    Zuidgeest, S
    Wildhagen, MF
    Van Helvoort, A
    JOURNAL OF UROLOGY, 2004, 171 (04): : 334 - 335
  • [45] Randomized, double-blind, placebo-controlled crossover study in men with prostate cancer and rising PSA:: Effectiveness of a dietary supplement
    Schröder, FH
    Roobol, MJ
    Boevé, ER
    de Mutsert, R
    Zuijdgeest-Van Leeuwen, SD
    Kersten, I
    Wildhagen, MF
    van Helvoort, A
    EUROPEAN UROLOGY, 2005, 48 (06) : 922 - 931
  • [46] A phase II trial of celecoxib in PSA recurrent prostate cancer after definitive radiation therapy or radical prostatectomy.
    Pruthi, RS
    Derksen, E
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 405S - 405S
  • [47] Phase II study of neoadjuvant 'supercastration' in men with high-risk prostate cancer
    Corcoran, N.
    Howard, N.
    Bugeja, P.
    Kerger, M.
    Moon, D.
    Clarke, D.
    Grummet, J.
    Hovens, C.
    Costello, T.
    Pedersen, J.
    Ryan, A.
    Ruljancich, P.
    Parente, P.
    BJU INTERNATIONAL, 2014, 113 : 18 - 18
  • [48] PSA and obesity among men with localized prostate cancer: results of the ANDROCAN study
    Meunier, Matthias E.
    Neuzillet, Yann
    Dreyfus, Jean-Francois
    Schneider, Marc
    Roupret, Morgan
    Cathelineau, Xavier
    Raynaud, Jean-Pierre
    Lebret, Thierry
    Botto, Henry
    WORLD JOURNAL OF UROLOGY, 2021, 39 (08) : 2945 - 2951
  • [49] PSA and obesity among men with localized prostate cancer: results of the ANDROCAN study
    Matthias E. Meunier
    Yann Neuzillet
    Jean-François Dreyfus
    Marc Schneider
    Morgan Rouprêt
    Xavier Cathelineau
    Jean-Pierre Raynaud
    Thierry Lebret
    Henry Botto
    World Journal of Urology, 2021, 39 : 2945 - 2951
  • [50] PSA surveillance following surgery for high risk prostate cancer with favourable pathological features
    Shaw, G. L.
    Thomas, B.
    Dawson, S.
    Gnanapragasam, V.
    Shah, N. C.
    Neal, D. E.
    BJU INTERNATIONAL, 2013, 111 : 40 - 40
12345